MedPath

A study to evaluate the usefulness of drug Gabapentin in reducing adverse symptoms after brain injury

Not Applicable
Completed
Conditions
Health Condition 1: S062- Diffuse traumatic brain injuryHealth Condition 2: S062- Diffuse traumatic brain injury
Registration Number
CTRI/2020/04/024537
Lead Sponsor
DR SURUCHI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

all patients of traumatic brain injury admitted in icu with age > 18 years and

Glasgow coma score of < 13

Exclusion Criteria

age < 18 years

pregnancy

known allergy to drug

known case of renal/hepatic dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath